Pablo Martinez

Clinical Development Oncology, MedImmune, Gaithersburg, EUA

Pablo Martinez is an Associate Director at the Department of Clinical Development Oncology at MedImmune HQ.

He designs innovative clinical trials to develop more rationale for new therapies against cancer in a more dynamic process and is responsible for the platform studies in Non-Small Cell Lung Cancer exploring new drug combinations in non-metastatic NSCLC.

Before his position at MedImmune PM had more than 10 years of academic experience in clinical and translational research. He has two MSc, one in Molecular Oncology and other in Advanced Immunology.

After obtaining his PhD he expended two years at Dana-Farber Cancer Institute at Pasi Janne’s Lab. He co-authors more than 25 peer-reviewed articles and has more than 800 citations. He is a member of different immunological and oncological societies.